A human genome editing-based MLL::AF4 B-cell ALL model recapitulates key cellular and molecular leukemogenic features Blood
Breaking the unvirtuous cycle: barriers and opportunities for research and development in Paraguay. A case study FRONT MED-LAUSANNE
CARD11 gain of function upregulates BCL2A1 and promotes resistance to targeted therapies combination in B-cell lymphoma Blood
Formation of an invasion-permissive matrix requires TGFβ/SNAIL1-regulated alternative splicing of fibronectin Breast Cancer Res
Endothelial activation and damage as a common pathological substrate in different pathologies and cell therapy complications FRONT MED-LAUSANNE
Integrated analysis of randomized controlled trials evaluating bortezomib + lenalidomide + dexamethasone or bortezomib + thalidomide + dexamethasone induction in transplant-eligible newly diagnosed multiple myeloma Front Oncol